These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 11498948

  • 1. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].
    Feng HS, Zang YM, Zhu MZ, Pei JM, Wang YM, Wang L, Shi PT.
    Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.
    Wei CM, Kim CH, Khraibi AA, Miller VM, Burnett JC.
    Hypertension; 1994 Jun; 23(6 Pt 2):903-7. PubMed ID: 8206626
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats].
    Dong MQ, Zhu MZ, Yu J, Shang LJ, Feng HS.
    Sheng Li Xue Bao; 2000 Jun; 52(3):252-4. PubMed ID: 11956575
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia.
    Barber MN, Gaspari TA, Kairuz EM, Dusting GJ, Woods RL.
    J Vasc Res; 2005 Jun; 42(2):101-10. PubMed ID: 15665545
    [Abstract] [Full Text] [Related]

  • 5. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation.
    Brunner F, Wölkart G.
    Microvasc Res; 2001 Jan; 61(1):102-10. PubMed ID: 11162200
    [Abstract] [Full Text] [Related]

  • 6. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
    Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A.
    Circulation; 2004 Sep 07; 110(10):1231-5. PubMed ID: 15337698
    [Abstract] [Full Text] [Related]

  • 7. Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries.
    Woodard GE, Li X, Brown J, Rosado JA.
    Regul Pept; 2005 Jul 15; 129(1-3):183-9. PubMed ID: 15927715
    [Abstract] [Full Text] [Related]

  • 8. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
    Hammerer-Lercher A, Fersterer J, Holzmann S, Bonatti J, Ruttmann E, Hoefer D, Mair J, Puschendorf B.
    Clin Sci (Lond); 2006 Sep 15; 111(3):225-31. PubMed ID: 16709152
    [Abstract] [Full Text] [Related]

  • 9. [The vasodilation and its mechanism of C-type natriuretic peptide].
    Wang YM, Pei JM, Zhu MZ, Zang YM, Li MZ, Nui GB, Shi F.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 May 15; 17(2):174-7. PubMed ID: 21171413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rainbow trout ventricular natriuretic peptide: isolation, sequencing, and determination of biological activity.
    Takei Y, Takano M, Itahara Y, Watanabe TX, Nakajima K, Conklin DJ, Duff DW, Olson KR.
    Gen Comp Endocrinol; 1994 Dec 15; 96(3):420-6. PubMed ID: 7883149
    [Abstract] [Full Text] [Related]

  • 12. AC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions.
    Chen BY, Chen JK, Zhu MZ, Zhang DL, Sun JS, Pei JM, Feng HS, Zhu XX, Jin J, Yu J.
    PLoS One; 2011 Dec 15; 6(5):e20477. PubMed ID: 21647224
    [Abstract] [Full Text] [Related]

  • 13. [Pulmonary artery in endotoxemia rat. Effects of atrial natriuretic peptide on relaxation and constriction of aorta and pulmonary artery in endotoxemia rat].
    Jia B, Li ZC, Zhang LL, Dong MQ, Wang YM, Zhou SS.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2004 May 15; 20(2):136-40. PubMed ID: 21166196
    [Abstract] [Full Text] [Related]

  • 14. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.
    Villar IC, Panayiotou CM, Sheraz A, Madhani M, Scotland RS, Nobles M, Kemp-Harper B, Ahluwalia A, Hobbs AJ.
    Cardiovasc Res; 2007 Jun 01; 74(3):515-25. PubMed ID: 17391657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells.
    Lu SY, Wang DS, Zhu MZ, Zhang QH, Hu YZ, Pei JM.
    Life Sci; 2005 May 20; 77(1):28-38. PubMed ID: 15848216
    [Abstract] [Full Text] [Related]

  • 19. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system.
    Sabbatini ME.
    Regul Pept; 2009 Apr 10; 154(1-3):5-15. PubMed ID: 19233231
    [Abstract] [Full Text] [Related]

  • 20. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
    Steinmetz M, Potthast R, Sabrane K, Kuhn M.
    Regul Pept; 2004 Jun 15; 119(1-2):31-7. PubMed ID: 15093694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.